Showing results (1-10 of 861) with videos related to
Sort By:
Pageof 87
Clinical Genetics|December 1, 1996
Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markersT H Fagerlund, G Islander, E Ranklev-Twetman, et al.Clinical Genetics|June 1, 1997
Malignant hyperthermia susceptibility, an autosomal dominant disorder?T H Fagerlund, G Islander, E Ranklev Twetman, et al.Clinical Genetics|March 31, 1998
Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutationT H Fagerlund, H Ording, D Bendixen, et al.Acta Anaesthesiologica Scandinavica|June 1, 1997
Results of in vitro contracture tests for the diagnosis of malignant hyperthermia susceptibility in monozygote twinsG Islander, E Ranklev TwetmanActa Anaesthesiologica Scandinavica|August 1, 1995
Evaluation of anaesthesias in malignant hyperthermia negative patientsG Islander, E Ranklev-TwetmanClinical Genetics|April 1, 1996
RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibilityT Fagerlund, H Ording, D Bendixen, et al.Neuromuscular Disorders : NMD|March 1, 1995
Malignant hyperthermia susceptibility without central core disease (CCD) in a family where CCD is diagnosedG Islander, K G Henriksson, E Ranklev-TwetmanAnesthesia and Analgesia|July 27, 2000
Between-center variability of results of the in vitro contracture test for malignant hyperthermia susceptibilityH Ording, G Islander, D Bendixen, et al.Acta Anaesthesiologica Scandinavica|October 9, 2002
Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibilityG Islander, H Ording, D Bendixen, et al.Acta Anaesthesiologica Scandinavica|May 1, 1996
Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probandsG Islander, D Bendixen, E Ranklev-Twetman, et al.Pageof 87